Genome-wide association studies have linked IL-23 to IBD susceptibility via polymorphisms in the IL-23 receptor (IL-23-R) gene that enhances the activity of the IL-17/IL-23 pathway [3]. The gene discussed is IL17A; the disease is inflammatory bowel disease.